Default: Cancer Biology and Therapy

ISSN: 1538-4047

Journal Home

Journal Guideline

Cancer Biology and Therapy Q1 Unclaimed

Landes Bioscience United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Biology and Therapy is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 113. It has an SJR impact factor of 1,166 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,166.

Cancer Biology and Therapy focuses its scope in these topics and keywords: cancer, cells, tumor, cell, proliferation, expression, progression, kinase, inhibits, melanoma, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cancer Biology and Therapy

1,166

SJR Impact factor

113

H Index

147

Total Docs (Last Year)

427

Total Docs (3 years)

5437

Total Refs

1748

Total Cites (3 years)

423

Citable Docs (3 years)

4,11

Cites/Doc (2 years)

36,99

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, cells, tumor, cell, proliferation, expression, progression, kinase, inhibits, melanoma, therapy, tyrosine, loss, human, pathway, vitro, apoptosis, carcinoma, gene, hepatocellular, inhibitor, metastasis, profiling, target, antitumor,



Best articles by citations

Maximizing early detection of esophageal squamous cell carcinoma via SILAC-proteomics

View more

Static magnetic fields impair angiogenesis and growth of solid tumors in vivo

View more

Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers

View more

Allosteric AKT inhibitors as a targeted cancer therapy

View more

Interleukin-2 gene transfer potentiates the a-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma

View more

In situ photoimmunotherapy: A new hope for cutaneous melanoma patients

View more

Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer

View more

Prostate cancer genomic signature offers prognostic value

View more

Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry

View more

The C-terminus of interferon gamma receptor beta chain (IFN gammaR2) has antiapoptotic activity as a bax inhibitor

View more

Isolated cardiac peripheral primitive neuroectodermal tumor: A case report

View more

Ethanol Treatment of Hepatocellular Carcinoma: High Potentials of Low Concentrations

View more
SHOW MORE ARTICLES

What accounts for the variable responses to progesterone on Schwann cells from mice and humans - the species-specific influence or the paracrine effects from the tumor microenvironment?

View more

Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation

View more

RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor

View more

Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis

View more

Minting a new class of Polo-like-kinase inhibitors

View more

A new look at molecular biology of breast cancer

View more

Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner

View more

EpCAM: A New Therapeutic Target for an Old Cancer Antigen

View more

Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs

View more

IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells

View more

Capsaicin reactivates hMOF in gastric cancer cells and induces cell growth inhibition

View more

Circulating tumor cells count and characterization in a male breast cancer patient

View more

FAQS